Zobrazeno 1 - 10
of 593
pro vyhledávání: ''
Autor:
Barbara Alicja Jereczek-Fossa, Giulia Marvaso, Massimo Sarra Fiore, Luca Bergamaschi, Fabrizio Mastrilli, Daniela Alterio, Giulia Corrao, Gabriella Pravettoni, Mattia Zaffaroni, Roberta Lazzari, Giammaria Bufi, Roberto Orecchia, Maria Cristina Leonardi, Federica Cattani
Publikováno v:
Tumori
Objective: During 2020, medical clinical activities were dramatically modified by the coronavirus disease 2019 (COVID-19) emergency. We aim to evaluate the impact of COVID-19 on radiotherapy (RT) practice in a hub cancer center. Methods: Retrospectiv
Autor:
Ugo Pastorino, Gabriella Sozzi, Inesa Hyseni, Donata Martinuzzi, Gianluca Milanese, Paola Suatoni, Alessandro Manenti, Livia Mazzini, Emanuele Montomoli, Stefano Sestini, Mattia Boeri, Giovanni Apolone, Laura Cantone, Federica Sabia, Alfonso Marchianò, Valentina Bollati
Publikováno v:
Tumori Journal. 107:446-451
There are no robust data on the real onset of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and spread in the prepandemic period worldwide. We investigated the presence of SARS-CoV-2 receptor-binding domain (RBD)–specific a
Publikováno v:
Tumori Journal. 107:424-431
Purpose: To explore the value of contrast-enhanced malignancy imaging features in secondary grade diagnosis of Breast Imaging Reporting and Data System for Ultrasonography (BI-RADS-US) type 4 breast lesions. Methods: After initial diagnosis by ultras
Autor:
Akihito Kubo, Masaya Fukami, Toshio Kato, Mika Sato, Hiroyuki Tanaka, Wataru Ohashi, Satoru Ito, Toshiyuki Yonezawa, Yasutaka Kato, Etsuro Yamaguchi, Kenshi Kosaka, Shigehisa Kajikawa
Publikováno v:
Tumori Journal. 107:385-391
Introduction: Increased serum procalcitonin (PCT), a well-known biomarker for sepsis, has been reported in several cancer types. We aimed to investigate the prognostic impact of PCT in non-small cell lung cancer (NSCLC). Methods: Medical records of 5
Publikováno v:
Tumori Journal. 107:329-334
Objective: There are limited data on tumour growth or pathologic upstaging in patients with early-stage lung cancer awaiting lung resection. We aimed to evaluate whether waiting times on the current lung cancer treatment pathway were associated with
Publikováno v:
Tumori Journal. 107:325-328
Background: Liquid-based cytology (LBC) tests, including the liquid-based thin layer method, have demonstrated the highest potential for reducing false-negatives and improving sample quality. Method: This study aimed to evaluate the diagnostic role o
Autor:
Guido Bonomo, Raffaella Cambria, Nicola Fazio, Dario Zerini, Matteo Pepa, Chiara Maria Grana, Pierpaolo Prestianni, Luigi Funicelli, Eleonora Pisa, Elisabetta Pennacchioli, Francesca Spada, Filippo Patti, Roberto Orecchia, Barbara Alicja Jereczek-Fossa
Publikováno v:
Tumori Journal. 107:145-149
Objective: To review the therapeutic strategy in Merkel cell carcinoma (MCC) treated with radiotherapy (RT) discussed in a multidisciplinary tumour board. Methods: Clinical records of patients with a diagnosis of MCC and with an indication to undergo
Autor:
Pinar Tasar, Nesrin Ugras, Aslı Ceren Macunluoğlu, Omer Yerci, Seçil Hasdemir, Halit Ziya Dündar
Publikováno v:
Tumori Journal. 107:80-85
Background: Pancreatic neuroendocrine neoplasms (NENs) are tumors with histopathologic and prognostic heterogeneity that pose difficulties in establishing standards for diagnosis, classification, and treatment. Among NENs, well-differentiated neuroen
Autor:
Lucia Bisceglia, Margherita Tanzarella, Vincenzo Coviello, Enrico Caputo, Anna Melcarne, Emma Cozzi, Fernando Palma, Francesco Cuccaro, Ivan Rashid, Maria Giovanna Burgio Lo Monaco
Publikováno v:
Tumori Journal. 107:39-45
Introduction:This study presents the incidence of gastrointestinal stromal tumors (GISTs) in an Italian region of over 4 million inhabitants monitored for 10 years and is the largest incidence study of this type of cancer conducted so far in Italy.Me
Autor:
Andrea Vingiani, Anna Borelli, Gianfranco Scaperrotta, Catherine Depretto, Francesco Cartia, Claudio Ferranti, Gabriele Presti, Alessandro Liguori
Publikováno v:
Tumori Journal. 106:491-496
Aim: To evaluate the presence of contrast enhancement at the site of calcifications on contrast-enhanced mammography (CEM) and histopathologic results at vacuum-assisted biopsy (VAB), and to examine the association with lesion size and immunohistoche